It has been reported that miR-34a influenced tumour biological activities by targeting several genes or signal pathways, such as CCND1 in EC [42], PDGFR in GC [18], HMGB1 in CRC [43], and XIST in PC [37]. This evidence concerns the gene HMGB1 and colorectal carcinoma.